Sumitomo Pharma Co., Ltd.JP:4506

Market cap

¥133.7B

P/E ratio

	Mar 31, 2013	Mar 31, 2014	Mar 31, 2015	Mar 31, 2016	Mar 31, 2017	Mar 31, 2018	Mar 31, 2019	Mar 31, 2020	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023
Revenue	-	-	-	-	-	466,838	459,267	482,732	515,952	560,035	555,544
Cost of sales	-	-	-	-	-	112,345	113,553	129,673	137,773	157,127	178,919
Gross profit	-	-	-	-	-	354,493	345,714	353,059	378,179	402,908	376,625
Selling, general and administrative expenses	-	-	-	-	-	183,651	180,439	154,348	190,373	249,081	373,316
Research and development expenses	-	-	-	-	-	86,928	102,364	115,112	132,682	94,903	131,858
Other income	-	-	-	-	-	9,417	885	1,404	17,662	2,406	53,256
Other expenses	-	-	-	-	-	5,158	5,912	1,764	1,562	1,096	1,686
Operating profit (loss)	-	-	-	-	-	88,173	57,884	83,239	71,224	60,234	-76,979
Finance income	-	-	-	-	-	2,430	7,369	3,568	9,213	25,777	32,218
Finance costs	-	-	-	-	-	5,737	207	2,860	2,586	3,050	3,159
Profit (loss) before tax	-	-	-	-	-	84,866	65,046	83,947	77,851	82,961	-47,920
Income tax expense	-	-	-	-	-	31,418	16,419	48,029	41,022	42,361	48,794
Profit (loss)	-	-	-	-	-	53,448	48,627	35,918	36,829	40,600	-96,714
Owners of parent	-	-	-	-	-	53,448	48,627	40,753	56,219	56,413	-74,512
Non-controlling interests	-	-	-	-	-	-	-	-4,835	-19,390	-15,813	-22,202
Profit (loss)	-	-	-	-	-	53,448	48,627	35,918	36,829	40,600	-96,714
Basic earnings (loss) per share	-	-	-	-	-	134.53	122.39	102.58	141.5	141.99	-187.55